Healthcare IT News Asia Pacific Announces Thai Edition

Food and Healthcare Press Releases Monday February 4, 2019 11:00
SINGAPORE--4 Feb--PRNewswire/InfoQuest
Following the official launch of the Asia Pacific regional edition of Healthcare IT News (HITN) in November 2018, HIMSS Asia Pacific today announced the launch of the Thai language edition of HITN.

HITN is the industry's authoritative source covering the people, policy, and technology driving next-generation healthcare. It focuses on news, features, analysis and decision content tied to healthcare information and technology. Key topics include analytics, artificial intelligence, cloud computing, EHR, government & policy, interoperability, patient engagement, population health, precision medicine, privacy & security, telehealth, and women in health IT.

HITN's global website generates on average 645,000 monthly page views from 292,000 unique monthly visitors.

"Thailand is known for its reputation as a medical tourism hub with its excellent private healthcare facilities and there are enormous opportunities for growth in terms of digital health. With the launch of the Thai edition of HITN, we hope that we can reach out to members of the Thai healthcare community more intimately, as well as offer local and international insights in healthcare trends and developments," says Simon Lin, Vice President APAC, HIMSS.

The Thai edition of HITN will be distributed weekly, with a relevant mix of local, regional and international news and analysis, says Dean Koh, HIMSS's APAC region editor. "The recent announcement of price controls on medical drugs, supplies and services in Thailand is something that we are watching with close interest, and we want to bring the latest developments and analysis to our readers."

About Healthcare IT News
Healthcare IT News is the industry's authoritative source covering the people, policy, and technology driving next-generation healthcare. www.healthcareitnews.com/asia-pacific.
About HIMSS

HIMSS is a global voice, advisor and thought leader of health transformation through health and information technology with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes. HIMSS designs and leverages key data assets, predictive models and tools to advise global leaders, stakeholders and influencers of best practices in health and information technology, so they have the right information at the point of decision. Through its health and information technology network of over 1 million experts, over 200 knowledge exchanges and collaborations, including 60,000-plus members, HIMSS drives innovative, forward thinking around best uses of technology in support of better connected care, improved population health and low cost of care. HIMSS is a not-for-profit, headquartered in Chicago, Illinois with additional offices in North America, Europe, United Kingdom and Asia.


Latest Press Release

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins. The acquisition includes...

Pneuma Respiratory, Inc. Announces New Chairman of the Board

Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation and...

Global market of dietary supplement is welcoming a rising star GLYMATE

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product,...

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Enterprise

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent...

SweeGen#s non-GMO Reb M Stevia Leaf Sweetener Approved in Singapore

SweeGen, Inc., a nature-based sweetener company, announced the Singapore Food Agency has added SweeGen's Reb M Stevia Leaf Sweetener to the list of permitted food additives. SweeGen's Reb M is a non-caloric stevia sweetener that provides sweetness with...

Related Topics